Derek Lowe of Corante comments on how the RD&A (research, development & [FDA] approval) cycle for drugs affects drug prices.
« Smelly Ketchup | Main | David Landau named new Haaretz editor »
February 14, 2004
Comments
The comments to this entry are closed.
Why the name?
Entre Nous
Rush: Permanent Waves
The theme song of this weblog
Recent Posts
- Academentia, part [lost count]
- Yellow badges for Jews in Iran?
- Michael Totten in Ramallah
- Dutch MP Ayaan Hirsi Ali leaves parliament and the Netherlands
- Fair Trade
- Political correctness gone rampant
- Iscar sold for USD$4B to Warren Buffett
- Porcupine Tree frontman moves to Tel-Aviv
- A cabinet is emerging
- The canard of "Hitler's 150,000 Jewish soldiers"
NewsBloggers
EssayBloggers
- Dr. Sanity
Blogging former NASA flight surgeon - Belmont Club
- TheMiddleGround
- Iain Murray
- james Lileks
- Oliver Kamm
- Steven Den Beste
Israeli bloggers
Belgian anti-Idiotarians
EuroBloggers
Abuse-Meisters
Other Blogs
- The Truth Laid Bear
- Balagan
- Andrew Sullivan
- Dr. Horsefeathers
- Virginia Postrel
- Live from Brussels
- Biased BBC
- the dissident frogman
- Thinking Meat
- Shark Blog
- Angie Schultz
- Lagniappe
- Silent Running
- Amish Tech Support
- Sasha & Andrew's Roundtable
- Jonathan Davis
- Setting The World To Rights
- Dilacerator
- Scrappleface
- Peaktalk
- Michael J. Totten
- Brink Lindsey
- Asymmetrical Information
- 100th Monkey
- ProperWinston
- St. Anger on the Left
- Tonecluster
- The Middle Ground
- Free Will
- Medpundit
- Israellycool
- Orson Scott Card
- Betsy's Page
- Ellisblog (W's cousin!)
- Eric S. Raymond
Alice/>
zymax weight loss drug
Posted by: Google | November 08, 2004 at 08:04 PM